We are live on ! Find out more
SPHS

Sophiris Bio
SPHS

Delisted

SPHS was delisted on the 11th of March, 2020.

19 hedge funds and large institutions have $3.31M invested in Sophiris Bio in 2016 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

9.23% less ownership

Funds ownership: 16.03% → 6.8% (-9.2%)

17% less funds holding

Funds holding: 23 → 19 (-4)

40% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 10

81% less capital inflows, than outflows

Capital inflows: $406K | Capital outflows: $2.17M

Holders
19
Holders Change
-4
Holders Change %
-17.39%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
5
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

SPHS Hedge Fund Activity: Q2 2016 in Review

19 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio (SPHS) for Q2 2016, worth a combined $3.31M — down 17% from $3.98M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of SPHS and 6 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 6 added.

The largest buyer was Vanguard Group, adding an estimated $217K. The largest seller was Boxer Capital, exiting entirely with an estimated $786K sold.

  • 19 institutional investors held Sophiris Bio (SPHS) as of Q2 2016, down from 23 in Q1 2016.
  • Funds reported $3.31M of Sophiris Bio stock for Q2 2016, down 17% quarter-over-quarter.
  • 6 funds opened new Sophiris Bio positions in Q2 2016 and 10 closed out, a net change of -4 holders.
  • The largest Sophiris Bio buyer in Q2 2016 was Vanguard Group, an estimated $217K added.
  • The largest Sophiris Bio seller in Q2 2016 was Boxer Capital, an estimated $786K sold.

Based on aggregated 13F filings for Q2 2016.